2025 annual financial data
Alamar Biosciences 2025 Operating margin
Direct answer
Operating margin was -42.22%.
Operating income was -31,334,000 USD and net income was -29,819,000 USD.
Operating cash flow was -53,608,000 USD.
Get free Alamar Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 74,211,000 USD
- Operating income
- -31,334,000 USD
- Net income
- -29,819,000 USD
- Operating cash flow
- -53,608,000 USD